Solventum Corporation (SOLV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Solventum Corporation (SOLV)
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Key Insights
Critical company metrics and information
Share Price
$69.55Market Cap
$12.02 BillionTotal Outstanding Shares
172.76 Million SharesTotal Employees
22,000Dividend
No dividendIPO Date
March 26, 2024SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.3m.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities | $-93.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-202.00 Million |
Net Cash Flow | $-126.00 Million |
Net Cash Flow, Continuing | $-126.00 Million |
Net Cash Flow From Operating Activities, Continuing | $169.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-93.00 Million |
Net Cash Flow From Operating Activities | $169.00 Million |
Net Cash Flow From Financing Activities | $-202.00 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Basic Average Shares | $173.40 Million |
Gross Profit | $1.17 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Attributable To Parent | $122.00 Million |
Income Tax Expense/Benefit | $45.00 Million |
Revenues | $2.08 Billion |
Costs And Expenses | $1.81 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $122.00 Million |
Selling, General, and Administrative Expenses | $701.00 Million |
Diluted Average Shares | $173.90 Million |
Income/Loss From Continuing Operations Before Tax | $167.00 Million |
Diluted Earnings Per Share | $0.70 |
Research and Development | $189.00 Million |
Benefits Costs and Expenses | $1.92 Billion |
Operating Expenses | $890.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income Tax Expense/Benefit, Deferred | $-37.00 Million |
Cost Of Revenue | $917.00 Million |
Basic Earnings Per Share | $0.70 |
Net Income/Loss | $122.00 Million |
Income/Loss From Continuing Operations After Tax | $122.00 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Operating Income/Loss | $275.00 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Other Non-current Assets | $7.14 Billion |
Intangible Assets | $2.65 Billion |
Equity | $3.19 Billion |
Wages | $251.00 Million |
Long-term Debt | $8.11 Billion |
Other Non-current Liabilities | $540.00 Million |
Noncurrent Assets | $11.39 Billion |
Assets | $14.74 Billion |
Noncurrent Liabilities | $8.65 Billion |
Inventory | $953.00 Million |
Fixed Assets | $1.60 Billion |
Other Current Assets | $2.40 Billion |
Current Assets | $3.35 Billion |
Other Current Liabilities | $2.09 Billion |
Equity Attributable To Parent | $3.19 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Liabilities And Equity | $14.74 Billion |
Liabilities | $11.55 Billion |
Accounts Payable | $560.00 Million |
Current Liabilities | $2.90 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.